Die Kombination aus einer oralen Antikoagulation und ASS wird in der Praxis häufig gesehen - ist jedoch oft nicht indiziert. Der Grund ist wahrscheinlich, dass Ärzte glauben, durch die Kombination thromboembolische Ereignisse besser verhindern zu können. Ob dies tatsächlich der Fall ist, hat eine US-amerikanische Registerarbeit nun systematisch untersucht.
Sep 2023
Trial of the Week: ATHOS-3
Trial of the Week: ATHOS-3 Angiotensin II for the Treatment of Vasodilatory ShockSpecial Guest: Dr. Ashish Khanna, MD, MS, FCCP, FCCM, FASA
Dr. Ashish Khanna joins me to highlight the ATHOS-3 trial, where Dr. Khanna is the principal investigator and first author of the NEJM publi ... Show More
40m 54s
Apr 2023
Infective Endocarditis-Associated Stroke
<p>Announcements: </p><p>The interactive <a href="https://clinicalpathways.ebmedicine.net/" style="color:rgb(0,80,165);">Clinical Pathways</a> have launched and they are available for free! </p><p></p><p>In this episode, Sam Ashoo, MD, and TR Eckler, MD, discuss the March 2023 Em ... Show More
43m 12s
Jun 2022
#342 Checkpoint Inhibitors: The power, and adverse effects, of immunotherapy (ACP 2022)
With great power comes great immunogenicity. Learn about the ins and outs of immunotherapy–its indications, its power, and its adverse effects–in this episode with Dr. Christian Cable, hematologist/oncologist and medical educator extraordinaire. We learn a riveting history of i ... Show More
54m 36s